Nicole Borsje | Head, IR |
Ming Hsieh | CEO |
Paul Kim | CFO |
Brandon Perthuis | Chief Commercial Officer |
Ladies and gentlemen, thank you for standing by. And welcome to the Q4 2019 Fulgent Genetics Earnings Conference Call. [Operator Instructions] Please be advised, that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Nicole Borsje, with Investor Relations.